Wed, Jan 10, 2024
Lupin said that it was the exclusive first-to-file for Bromfenac Ophthalmic Solution, 0.07%, and is eligible for 180-day exclusivity.
More >
Thu, Jan 04, 2024
Stocks to watch on Friday, January 5: Lupin got a receipt of tentative approval from the U.S. Food and Drugs Administration (USFDA) for Dapagliflozin and Saxagliptin tablets.
Tue, Jan 02, 2024
At around 9:55 a.m., shares of Lupin traded up by 4.51 per cent or Rs 59.2 at Rs 1371.85 apiece. The market capitalisation of the pharmaceutical company stood at Rs 62,457.14 crore at the same time.
Wed, May 10, 2023
Which stocks to buy, hold or sell today? As Dalal Street enters the May 10 session, here's a look at what brokerages make of some of the key stocks in focus. On their radar are stocks such as Lupin, Godrej Consumer Products, Zomato and Apollo Tyres.
Tue, May 09, 2023
How will be the results of Lupin? How will be the profits and margins in Q4? How much income possible in March quarter? Know the complete details from Nupur.
Fri, Mar 31, 2023
The US Food and Drug Administration (USFDA) inspected Lupin's Pithampur plant from March 21 to March 29, 2023, and ended the inspection by issuing a Form-483 with ten observations, the drugmaker said in a filing. Lupin shares have been a top loser in the pharma pack today.
Ajanta Pharma, Welspun, Lupin, Mindtree, among other stocks are in focus on the back of either stock-related news or corporate action on Friday, March 31, 2023.
Thu, Mar 30, 2023
In November last year, USFDA had issued Form-483 with eight observations each for product and raw material production centres at Lupin's Mandideep-based manufacturing facility.
Tue, Mar 28, 2023
Pharma stocks were a mixed bag on Tuesday, as Sun Pharma, Lupin, Biocon, Aurobindo Pharma, Pfizer, Granules and Glaxosmith succumbed to selling pressure, and Cipla, Natco Pharma, Glenmark, Dr Reddy, Abbott India and Ipca Labs managed to eke out gains. Drug pricing regulator NPPA fixed retail prices of 25 formulations.
Mon, Mar 27, 2023
A ransomware group has claimed responsibility for the 'IT security incident' at Sun Pharma whose effect included a breach of certain file systems and the theft of certain company data and personal data, the drugmaker said.
Lupin shares surged on Friday after the pharmaceutical major received nod from the US Food and Drug Administration (FDA) for valbenazine capsules, used in the treatment of adults with tardive dyskinesia, a medical condition that affects a person's movement and facial tics like lip-smacking and grimacing.
Tue, Mar 14, 2023
Lupin, Sun Pharma share price: Wild swings in the Indian share market come in the backdrop of sharp falls in the global markets owing to weakness in the banking space, after the collapse of US-based startup lender Silicon Valley Bank following a failed attempt to raise capital.
GAIL, Sona BLW Precision Forgings Nalco, Hudco, Astral, Lupin, Data Patterns, Global Surfaces, PNB Housing, Divgi TorqTransfer Systems, Mahindra and Mahindra among others are in focus on the back of either stock-related news or various corporate actions on Tuesday, March 14, 2023.
Fri, Feb 10, 2023
Lupin Q3 result: Drug maker Lupin has reported 72 per cent decline in consolidated net profit at Rs 153 crore for the third quarter ended December 31, 2022.
Thu, Feb 09, 2023
Lupine results will come today. How will be the results of Lupin in Q3? How will be profits and margins in Q3? Know from Nupur.
Sat, Feb 04, 2023
Lupin arm recalls cream tubes: Lupin Pharmaceuticals Inc is recalling Clobetasol propionate Cream, a steroid to reduce inflammation, redness and itchiness of the skin and prevent further irritation of the skin.
Wed, Jan 11, 2023
Jefferies and HSBC have recommended, Cipla, Sun Pharma, Divi's Laboratories, Biocon, Lupin and others
Fri, Dec 23, 2022
Why Astha Jain suggests to buy Lupin on Technical Charts? Watch this video for more details.
Tue, Nov 29, 2022
Technical expert Simi Bhaumik expects an upside of Rs 25-30 which will open if the stock decisively breaches levels of Rs 759, its November high.
In today's edition of Traders Diary, Zee Business research team brings its exclusive research on 20 stocks that investors and traders can refer to while making their strategies in them
Tue, Nov 15, 2022
Thu, Nov 10, 2022
Shares of Lupin rallied 3% on Nov 10 after the company announced a consolidated net profit of Rs 130 crore for September quarter 2022-23
Lupin Share Price: The drug maker on Wednesday said its consolidated net profit stood at Rs 130 crore for the second quarter ended September 30, 2022.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
